Monday, May 6, 2013
Under PDUFA V, FDA committed to hold a series of
meetings to obtain patient input on 20 diseases as part of the agency's
Patient-Focused Drug Development initiative. Last September, FDA solicited
public comments on a preliminary list of 39 disease candidates. This month,
agency announced the first 16, which will be discussed during fiscal 2013-15.
It includes four diseases